Tenet Healthcare Beheer
Beheer criteriumcontroles 2/4
De CEO Tenet Healthcare is Saum Sutaria, benoemd in Sep2021, heeft een ambtstermijn van 3.17 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 18.52M, bestaande uit 8.1% salaris en 91.9% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.29% van de aandelen van het bedrijf, ter waarde $ 45.30M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.7 jaar en 6.5 jaar.
Belangrijke informatie
Saum Sutaria
Algemeen directeur
US$18.5m
Totale compensatie
| Percentage CEO-salaris | 8.1% |
| Dienstverband CEO | 3.2yrs |
| Eigendom CEO | 0.3% |
| Management gemiddelde ambtstermijn | 3.7yrs |
| Gemiddelde ambtstermijn bestuur | 6.5yrs |
Recente managementupdates
Recent updates
Tenet Healthcare: Targeting More Stable Demand In High-Acuity Services
Nov 04With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case
Oct 30
Tenet Healthcare: Becoming A Very Healthy Business
Sep 09Earnings Working Against Tenet Healthcare Corporation's (NYSE:THC) Share Price
Sep 06Tenet Healthcare: Strong EPS Growth, But Shares Near FV (Rating Downgrade)
Aug 29Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden
Aug 13An Intrinsic Calculation For Tenet Healthcare Corporation (NYSE:THC) Suggests It's 42% Undervalued
Jul 11Tenet Healthcare: Asset Sales, Current Multiples Support Re-Rating (Rating Upgrade)
Jun 17With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case
May 21Tenet Healthcare Corporation's (NYSE:THC) Shareholders Might Be Looking For Exit
Apr 30Does Tenet Healthcare (NYSE:THC) Have A Healthy Balance Sheet?
Mar 18Tenet Healthcare: Shrinking To Grow
Feb 04Tenet Healthcare Corporation (NYSE:THC) Might Not Be As Mispriced As It Looks
Dec 18We Think Tenet Healthcare (NYSE:THC) Is Taking Some Risk With Its Debt
Nov 15Tenet Healthcare: A Compelling Opportunity Despite Lofty Debt
Oct 13Is Tenet Healthcare (NYSE:THC) Using Too Much Debt?
Aug 02Tenet Healthcare: Muted Earnings Outlook Doesn't Inspire Confidence For Now
Jul 28Does This Valuation Of Tenet Healthcare Corporation (NYSE:THC) Imply Investors Are Overpaying?
Apr 13USPI and Providence extend hands to aid ambulatory surgical services
Feb 09Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden
Jan 31Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$3b |
| Jun 30 2024 | n/a | n/a | US$3b |
| Mar 31 2024 | n/a | n/a | US$3b |
| Dec 31 2023 | US$19m | US$2m | US$611m |
| Sep 30 2023 | n/a | n/a | US$469m |
| Jun 30 2023 | n/a | n/a | US$499m |
| Mar 31 2023 | n/a | n/a | US$414m |
| Dec 31 2022 | US$11m | US$1m | US$410m |
| Sep 30 2022 | n/a | n/a | US$558m |
| Jun 30 2022 | n/a | n/a | US$875m |
| Mar 31 2022 | n/a | n/a | US$957m |
| Dec 31 2021 | US$21m | US$1m | US$915m |
| Sep 30 2021 | n/a | n/a | US$1b |
| Jun 30 2021 | n/a | n/a | US$434m |
| Mar 31 2021 | n/a | n/a | US$402m |
| Dec 31 2020 | US$9m | US$1m | US$399m |
| Sep 30 2020 | n/a | n/a | -US$18m |
| Jun 30 2020 | n/a | n/a | -US$48m |
| Mar 31 2020 | n/a | n/a | -US$112m |
| Dec 31 2019 | US$14m | US$962k | -US$226m |
Compensatie versus markt: De totale vergoeding ($USD 18.52M ) Saum } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 12.73M ).
Compensatie versus inkomsten: De vergoeding van Saum is het afgelopen jaar met meer dan 20% gestegen.
CEO
Saum Sutaria (51 yo)
3.2yrs
Tenure
US$18,518,110
Compensatie
Dr. Saumya Sutaria, M.D., also known as Saum, serves as Member of Advisory Board at Vida Health, Inc. Dr. Sutaria served as Chief Operating Officer at Tenet Healthcare Corp. since January 06, 2019 until S...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chairman & CEO | 3.2yrs | US$18.52m | 0.29% $ 45.3m | |
| Executive VP & Chief Information Officer | 6.5yrs | US$2.47m | 0.023% $ 3.6m | |
| EVP, Chief Administrative Officer | 3.7yrs | US$3.67m | 0% $ 0 | |
| Executive Vice President of Commercial Operations | 2.7yrs | US$3.24m | 0.016% $ 2.6m | |
| Executive VP & CFO | less than a year | geen gegevens | geen gegevens | |
| Vice President of Investor Relations | no data | geen gegevens | geen gegevens | |
| Senior VP & Chief Compliance Officer | no data | geen gegevens | geen gegevens | |
| Executive Vice President of Corporate Development | 7.8yrs | geen gegevens | geen gegevens | |
| Chief Managed Care Officer & Senior VP | 17.3yrs | geen gegevens | geen gegevens | |
| Chief Applied Clinical Informatics Officer | no data | geen gegevens | geen gegevens | |
| Chief Administrative Officer - USPI | 1.8yrs | geen gegevens | geen gegevens | |
| Senior Vice President & Chief Clinical Operations Officer | 5.8yrs | geen gegevens | geen gegevens |
3.7yrs
Gemiddelde duur
55yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van THC wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.7 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chairman & CEO | 4yrs | US$18.52m | 0.29% $ 45.3m | |
| Independent Director | 7.1yrs | US$333.54k | 0.040% $ 6.3m | |
| Independent Director | 1.5yrs | US$238.93k | 0% $ 0 | |
| Independent Director | 6.5yrs | US$339.04k | 0.0081% $ 1.3m | |
| Lead Independent Director | 23.7yrs | US$541.53k | 0.024% $ 3.8m | |
| Independent Director | 7yrs | US$335.04k | 0.018% $ 2.9m | |
| Independent Director | 7yrs | US$351.04k | 0.0070% $ 1.1m | |
| Independent Director | 9.7yrs | US$356.04k | 0.051% $ 8.1m | |
| Independent Director | 5.3yrs | US$331.04k | 0.00029% $ 46.0k | |
| Executive Chairman of Aspen Healthcare | no data | geen gegevens | geen gegevens | |
| Independent Director | 3.8yrs | US$327.04k | 0.0018% $ 280.8k | |
| Independent Director | 5.1yrs | US$320.04k | 0.021% $ 3.3m |
6.5yrs
Gemiddelde duur
67yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van THC wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.5 jaar).